Holders

BRIDGEBIO PHARMA INC

Q1 2026 13F holders

CUSIP
10806XAJ1
Type
Debt
Class
NOTE 1.750% 3/0
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Principal Option type